Brief: Epigenomics FY Net Loss Narrows To EUR 10.2 Million

Epigenomics AG

23/03/2018 07:27

March 23 (Reuters) - EPIGENOMICS AG  ECXn.DE :
    * IN 2017, EPIGENOMICS' TOTAL REVENUE DECREASED TO EUR 1.9
MILLION
(2016: EUR 4.2 MILLION)
    * FY RESEARCH AND DEVELOPMENT COSTS DECREASED TO EUR 4.3
MILLION
(2016: EUR 5.1 MILLION)
    * FY OPERATING LOSS (EBIT) IN 2017 DECREASED TO EUR -10.3
MILLION
(2016: EUR -12.3 MILLION)
    * FY NET LOSS FOR YEAR DECREASED TO EUR 10.2 MILLION (2016:
EUR
11.2 MILLION
    * SEES FY 2018 REVENUE TO INCREASE BUT WILL REMAIN ON LOW
LEVELS,
RANGING BETWEEN EUR 2.0 MILLION AND EUR 4.0 MILLION
    * ANTICIPATES EBITDA BEFORE SHARE-BASED PAYMENT EXPENSES
WILL BE
IN A RANGE EUR -11.5 MILLION AND EUR -14.0 MILLION IN 2018
    * EXPECTS 2018 CASH CONSUMPTION IN LINE WITH OUR EBITDA
BEFORE
SHARE-BASED PAYMENT EXPENSES GUIDANCE

Source text for Eikon:  ID:nEQbLl907a 
Further company coverage:  ECXn.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))